Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,692
Total Claims
$1.2M
Drug Cost
659
Beneficiaries
$1,758
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+9%
Opioid rate vs peers
2.8% vs 2.6% avg
+65%
Cost per patient vs peers
$1,758 vs $1,068 avg
+14%
Brand preference vs peers
10.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.8%
Opioid Rate
330
Opioid Claims
$5,995
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,192 claims · $921K
Generic: 10,400 claims · $233K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 78 | $101K |
| Sitagliptin Phosphate | 64 | $87K |
| Semaglutide | 66 | $80K |
| Insulin Glargine,hum.Rec.Anlog | 52 | $78K |
| Insulin Detemir | 19 | $39K |
| Dulaglutide | 14 | $35K |
| Empagliflozin | 23 | $34K |
| Sacubitril/Valsartan | 24 | $34K |
| Dapagliflozin Propanediol | 20 | $34K |
| Rivaroxaban | 27 | $32K |
| Budesonide/Formoterol Fumarate | 31 | $29K |
| Tirzepatide | 22 | $25K |
| Insulin Aspart | 12 | $24K |
| Linagliptin | 11 | $18K |
| Fluticasone/Umeclidin/Vilanter | 11 | $17K |
Prescribing Profile
Patient Profile
71
Avg Age
47%
Female
1.85
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About